KRAS-mutant circulating tumor DNA is associated with worse overall survival in localized pancreatic ductal adenocarcinoma.
Patients using GLP-1 RAs may experience dermatologic adverse side effects, including skin laxity, hair shedding, and facial ...
Daraxonrasib significantly prolonged survival in previously treated mPDAC, supporting its use as a new treatment option for patients with RAS-driven disease. Daraxonrasib prolongs overall and ...
The study findings support the use of bepirovirsen as a finite-duration therapy capable of achieving sustained off-treatment viral control. Functional cure of chronic hepatitis B virus (HBV) infection ...
While the role of the gut-joint axis has been recognized in SpA, evidence shows diet should be used as an adjunct to ...
The FDA has granted accelerated approval to Tzield to delay the decline in endogenous insulin production in children recently diagnosed with stage 3 T1D.
Controlled attenuation parameter-measured hepatic steatosis independently predicts greater coronary artery disease complexity in patients with AMI. Patients with acute myocardial infarction (AMI) and ...
There was a significant inflection in call volume, with semaglutide exposures increasing an additional 9.9% per quarter after FDA approval. (HealthDay News) — Glucagon-like peptide-1 receptor agonist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results